Superworth10x Genomics market cap TXG
Share price times shares outstanding: what the whole company sells for, since 2019.
- Today, Oct 23, 2026
- $9.3B
- Highest close in our data
- $21.5B
- Apr 2021
10x Genomics is worth $9.3B at the close on Oct 23, 2026, at $71.55 a share.
That is up 444% over the last year and down 48% over five years.
Its highest close in our data was $21.5B in Apr 2021.
Market cap over time
Year by year
| Year | End of year | Low | High | Change |
|---|---|---|---|---|
| 2026 so far | $9.3B | $2.1B | $12.2B | +347% |
| 2025 | $2.1B | $913.6M | $2.4B | +18% |
| 2024 | $1.8B | $1.6B | $6.1B | −73% |
| 2023 | $6.6B | $4.2B | $7.3B | +59% |
| 2022 | $4.2B | $2.9B | $14.3B | −75% |
| 2021 | $16.6B | $15.4B | $21.5B | +9% |
| 2020 | $15.2B | $5.4B | $16.5B | +103% |
| 2019 | $7.5B | $5.9B | $7.5B | n/a |
Against its peers
Companies in Medical - Diagnostics & Research nearest 10x Genomics' size, closest first, today.
| Company | Market cap |
|---|---|
| TXG10x Genomics | $9.3B |
| CAICaris Life Sciences | $9B |
| BIOBio-Rad Laboratories | $9.9B |
| LNTHLantheus | $6.5B |
| BLLNBillionToOne | $5.1B |
| RVTYRevvity | $17.7B |
| MEDPMedpace | $18.7B |
| VCYTVeracyte | $3.9B |
| CDNACareDx | $3.6B |
| LHLabcorp | $26.7B |
| DGXQuest Diagnostics | $26.7B |
| Peer median | $9.5B |
What the market cap tells you
Share price times shares outstanding: what the whole company sells for today.
Size, not quality. Large caps move slower and are covered more. That is all it tells you.
More on 10x Genomics
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.